An action spectrum for the production of cis-urocanic acid in human skin in vivo.

Urocanic acid (UCA) is present at millimolar concentrations in mammalian epidermis and undergoes photoisomerization from the naturally occurring trans-isomer to the cis-isomer on exposure to ultraviolet radiation (UVR). Cis-UCA causes downregulation of various immune responses in mouse and human experimental models and has been proposed as both a chromophore and a mediator of UV-induced immune suppression. In this study, the wavelength dependence from 260-340 nm for trans to cis-UCA photoisomerization in human skin was analyzed in five healthy volunteers. The resulting action spectrum demonstrated maximal cis-UCA production in the UVB spectral region of 280-310 nm. This spectral peak is red-shifted to longer wavelengths compared with the erythemal action spectrum. The cis-UCA action spectrum can be used to predict the ability of sunscreens to protect against UVR-induced cis-UCA formation and may assist in explaining discrepancies between sunscreens' abilities to protect against erythema and photoimmunosuppression.

[1]  A. Fourtanier,et al.  High ultraviolet A protection affords greater immune protection confirming that ultraviolet A contributes to photoimmunosuppression in humans. , 2003, The Journal of investigative dermatology.

[2]  M. Kripke,et al.  Viability of the Antigen Determines Whether DNA or Urocanic Acid Act as Initiator Molecules for UV-induced Suppression of Delayed-type Hypersensitivity¶ , 2003, Photochemistry and photobiology.

[3]  G. Halliday,et al.  Prevention of immunosuppression by sunscreens in humans is unrelated to protection from erythema and dependent on protection from ultraviolet a in the face of constant ultraviolet B protection. , 2003, The Journal of investigative dermatology.

[4]  M. Norval,et al.  Studies to determine the immunomodulating effects of cis-urocanic acid. , 2002, Methods.

[5]  M. Kripke,et al.  Mechanisms underlying the suppression of established immune responses by ultraviolet radiation. , 2002, The Journal of investigative dermatology.

[6]  M. Norval,et al.  IL-12 Prevents the Inhibitory Effects of cis-Urocanic Acid on Tumor Antigen Presentation by Langerhans Cells: Implications for Photocarcinogenesis1 , 2001, The Journal of Immunology.

[7]  F. Claas,et al.  Broad-spectrum sunscreens offer protection against urocanic acid photoisomerization by artificial ultraviolet radiation in human skin. , 2000, The Journal of investigative dermatology.

[8]  A. Fourtanier,et al.  Improved protection against solar-simulated radiation-induced immunosuppression by a sunscreen with enhanced ultraviolet A protection. , 2000, The Journal of investigative dermatology.

[9]  Kimber,et al.  The effects of ultraviolet radiation on the human immune system , 1999, The British journal of dermatology.

[10]  J. Simon,et al.  Epidermal trans-urocanic acid and the UV-A-induced photoaging of the skin. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[11]  F. Claas,et al.  Differential Suppression of the Human Mixed Epidermal Cell Lymphocyte Reaction (MECLR) and Mixed Lymphocyte Reaction (MLR) by Cis‐Urocanic Acid , 1997, Photochemistry and photobiology.

[12]  M. Kripke,et al.  Chromophore for UV‐induced Immunosuppression: DNA , 1996, Photochemistry and photobiology.

[13]  M. Norval,et al.  Urocanic acid isomers in human skin: analysis of site variation , 1995, The British journal of dermatology.

[14]  M. A. Rie,et al.  Photoisomerization spectrum of urocanic acid in human skin and in vitro: effects of simulated solar and artificial ultraviolet radiation , 1995, The British journal of dermatology.

[15]  P. Hart,et al.  Cis‐UROCANIC ACID SYNERGIZES WITH HISTAMINE FOR INCREASED PGE2 PRODUCTION BY HUMAN KERATINOCYTES: LINK TO INDOMETHACIN‐INHIBITABLE UVB‐INDUCED IMMUNOSUPPRESSION , 1995, Photochemistry and photobiology.

[16]  J. Punnonen,et al.  Effects of cis- and trans-urocanic acids on the secretion of interleukin-1 beta and tumour necrosis factor-alpha by human peripheral blood monocytes. , 1994, Acta dermato-venereologica.

[17]  M. Norval,et al.  Effect of phototherapy and urocanic acid isomers on natural killer cell function. , 1993, The Journal of investigative dermatology.

[18]  K. Jones,et al.  Cis-urocanic acid stimulates human peripheral blood monocyte prostaglandin E2 production and suppresses indirectly tumor necrosis factor-alpha levels. , 1993, Journal of immunology.

[19]  N. Traynor,et al.  ACTION SPECTRA FOR THE trans TO cis PHOTOISOMERISATION OF UROCANIC ACID in vitro and IN MOUSE SKIN , 1993, Photochemistry and photobiology.

[20]  K. Lammintausta,et al.  A non-invasive chamber sampling technique for HPLC analysis of human epidermal urocanic acid isomers. , 1991, Acta dermato-venereologica.

[21]  T. Reunala,et al.  Cis-urocanic acid stereospecifically modulates human monocyte IL-1 production and surface HLA-DR antigen expression, T-cell IL-2 production and CD4/CD8 ratio. , 1989, Photo-dermatology.

[22]  G. Greenoak,et al.  TOPICAL UROCANIC ACID ENHANCES UV‐INDUCED TUMOUR YIELD AND MALIGNANCY IN THE HAIRLESS MOUSE , 1989, Photochemistry and photobiology.

[23]  S. Howie,et al.  Quantification of urocanic acid isomers in murine skin during development and after irradiation with UVB light. , 1988, Photo-dermatology.

[24]  H. Morrison,et al.  A WAVELENGTH EFFECT ON UROCANIC ACID E/Z PHOTOISOMERIZATION * , 1984, Photochemistry and photobiology.

[25]  F. Noonan,et al.  Mechanism of immune suppression by ultraviolet irradiation in vivo. I. Evidence for the existence of a unique photoreceptor in skin and its role in photoimmunology , 1983, The Journal of experimental medicine.

[26]  M. S. Fisher,et al.  Systemic alteration induced in mice by ultraviolet light irradiation and its relationship to ultraviolet carcinogenesis. 1977. , 1977, Bulletin of the World Health Organization.